[Clinicopharmacological studies on the bronchoconstrictive side effect of the beta-receptor blockader talinolol (Cordanum, 02-115) in patients with asthma or chronic obstructive lung diseases].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D001249:Asthma / Q000503:physiopathology; D001980:Bronchi / Q000187:drug effects*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008173:Lung Diseases, Obstructive / Q000503:physiopathology; D008297:Male; D011217:Practolol / Q000009:adverse effects; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects*; D014797:Vital Capacity / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D011217:Practolol
Klinisch-pharmakologische Untersuchungen zur bronchokonstriktorischen Nebenwirkung des beta 1-Rezeptorenblockers Talinolol (Cordanum, 02-115) bei Asthmatikern und Patienten mit chronischen obstruktiven Lungenerkrankungen